Clinical Trial Update: Levetiracetam Treatment in Adult Subjects With Parkinson's Disease Experiencing Troublesome Dyskinesias [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating levetiracetam for troublesome dyskinesias in adults with Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• LEVETIRACETAM (levetiracetam)

Snippet

Sponsor: UCB Pharma | Conditions: Idiopathic Parkinson Disease | Phase 2 | Status: COMPLETED